Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EPS (Basic): 2009-2025

Historic EPS (Basic) for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to $1.30.

  • Innoviva's EPS (Basic) rose 6400.00% to $1.30 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.40, marking a year-over-year increase of 2762.59%. This contributed to the annual value of $0.37 for FY2024, which is 86.55% down from last year.
  • Latest data reveals that Innoviva reported EPS (Basic) of $1.30 as of Q3 2025, which was up 28.71% from $1.01 recorded in Q2 2025.
  • In the past 5 years, Innoviva's EPS (Basic) registered a high of $3.81 during Q3 2022, and its lowest value of -$0.74 during Q1 2025.
  • For the 3-year period, Innoviva's EPS (Basic) averaged around $0.29, with its median value being $0.02 (2024).
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 2,850.00% in 2024, then surged by 6,400.00% in 2025.
  • Innoviva's EPS (Basic) (Quarterly) stood at -$0.09 in 2021, then tumbled by 70.06% to -$0.15 in 2022, then soared by 30.65% to -$0.10 in 2023, then crashed by 64.02% to -$0.17 in 2024, then skyrocketed by 6,400.00% to $1.30 in 2025.
  • Its EPS (Basic) was $1.30 in Q3 2025, compared to $1.01 in Q2 2025 and -$0.74 in Q1 2025.